Rostock University Medical Center

At Rostock University Medical Center, a large share of trials focuses on cancer and blood cancers, including acute myeloid leukemia, lymphoma, multiple myeloma, prostate cancer, and colorectal cancer. These studies aim to improve treatment effectiveness, refine transplant-based care, and test newer combinations that may offer better disease control.

• Acute leukemia and myelodysplastic syndromes evaluating improved treatment strategies before and after transplantation
• Lymphomas and chronic lymphocytic leukemia: testing targeted and immune-based approaches to extend remission
• Solid tumors such as prostate, breast, lung, and head and neck cancers: assessing new therapies and better disease monitoring

Many of these trials are designed to compare current standard care with newer options, with the goal of improving survival, reducing relapse, and supporting more personalized oncology treatment.

The site also has strong activity in neurology and mental disorders, especially studies in Alzheimer’s disease, vascular dementia, multiple sclerosis, and amyotrophic lateral sclerosis. Research here is centered on finding better ways to slow disease progression, improve symptom control, and strengthen diagnostic accuracy.

• Alzheimer’s disease and related dementias: evaluating treatments and imaging tools that may support earlier and more precise diagnosis
• Amyotrophic lateral sclerosis: testing therapies intended to slow functional decline and improve safety
• Relapsing multiple sclerosis: studying approaches that reduce new disease activity and support long-term control

Several trials focus on whether emerging therapies can better preserve quality of life and delay progression in these challenging neurological conditions.

Another important research area at Rostock University Medical Center is gastroenterology and immune-mediated disease, alongside dermatology. Trials include Crohn’s disease, ulcerative colitis, atopic dermatitis, psoriasis, and hidradenitis suppurativa, with a focus on reducing inflammation and improving day-to-day symptoms.

• Crohn’s disease and ulcerative colitis: testing new anti-inflammatory treatments for better disease control
• Atopic dermatitis and plaque psoriasis: evaluating therapies that may reduce skin symptoms and improve comfort
• Hidradenitis suppurativa: studying options for a difficult-to-treat chronic inflammatory skin condition

These studies aim to improve both symptom relief and long-term disease management for patients with chronic inflammatory disorders.

The clinical trial portfolio also includes cardiovascular disease, respiratory disease, and critical care. Research topics range from atrial fibrillation and heart failure to asthma, severe lung infections, and care for critically ill patients. The overall aim is to improve prevention, safety, and treatment outcomes in high-risk settings.

• Atrial fibrillation and stroke prevention: evaluating ways to reduce clot-related complications and bleeding risk
• Asthma and severe respiratory illness: testing therapies that may improve breathing control and reduce exacerbations
• Critical illness: studying supportive care strategies that may improve recovery in intensive care

This area reflects a strong interest in managing acute and chronic conditions where treatment decisions can have immediate impact on patient outcomes.

Research in urology and diagnostic imaging is another visible theme, with studies in prostate cancer, bladder neoplasms, and related disease states. The site is also involved in trials evaluating imaging-based diagnosis and treatments that support procedures or urgent interventions.

• Prostate cancer: assessing imaging tools and new treatment options for localized and metastatic disease
• Urinary tract and bladder disorders: exploring better ways to identify and manage urologic disease
• Urgent procedural care: testing approaches that help manage bleeding risk and treatment reversal when rapid intervention is needed

These trials combine practical clinical questions with efforts to improve precision in diagnosis and safety in treatment planning.

The site contributes to pediatric oncology and rare disease research, including acute lymphoblastic leukemia, lymphoblastic lymphoma, Ewing sarcoma, medulloblastoma, and other uncommon tumors. These studies focus on improving cure rates while limiting treatment burden for children and adolescents.

• Childhood leukemia and lymphoma: testing optimized treatment strategies to improve survival and reduce relapse
• Brain tumors and sarcomas: evaluating therapies intended to strengthen disease control in rare cancers
• Genetic and high-risk pediatric cancers: studying more individualized approaches for difficult-to-treat disease

This research supports ongoing efforts to tailor care for younger patients with complex and often aggressive conditions.